The Science Behind Oral GLP-1 Therapies
Oral GLP-1 receptor agonists (like semaglutide tablets) work in the same way as injectable GLP-1 drugs, but with some differences…
Tag: Drugs
The Next Ozempic? Tufts’ 4-in-1 Weight Loss Drug Could Redefine Obesity Treatment
Weight loss science is entering a new era. For years, drugs like Ozempic and Wegovy have transformed how doctors treat…
The Risky Rise of DIY Weight-Loss Drugs: Americans Turning to Unregulated Imports
As demand for weight-loss medications like Wegovy (semaglutide) and Zepbound (tirzepatide) skyrockets, a growing number of Americans are bypassing traditional healthcare systems and turning…
10 quick-tips to help tackle obesity in the USA
More than 70 million American adults—equally split between 35 million men and 35 million women—are classified as obese. Additionally, 99…
Diabesity: The Rising Challenge of Diabetes and Obesity and How Biocon is Taking the Lead
In the world of modern healthcare, there’s a new term that’s creating waves: Diabesity. Coined to capture the dual epidemic…
Retatrutide: The Next-Gen ‘Triple G’ Weight Loss Drug Shows Promising Results
Retatrutide is a promising experimental weight loss drug under development by Eli Lilly. Known as the “Triple G” drug, it…
Semaglutide in the ESSENCE Trial: A Breakthrough for Liver Disease Treatment?
Liver disease, especially metabolic dysfunction-associated steatohepatitis (MASH), has long been a silent threat, affecting millions of people globally. Often progressing…